Cargando…
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine
The mRNA vaccines for SARS-CoV-2 have demonstrated efficacy and immunogenicity in the real-world setting. However, most of the research on vaccine immunogenicity has been centered on characterizing the antibody response, with limited exploration into the persistence of spike-specific memory B cells....
Autores principales: | Ciabattini, Annalisa, Pastore, Gabiria, Lucchesi, Simone, Montesi, Giorgio, Costagli, Simone, Polvere, Jacopo, Fiorino, Fabio, Pettini, Elena, Lippi, Arianna, Ancillotti, Leonardo, Tumbarello, Mario, Fabbiani, Massimiliano, Montagnani, Francesca, Medaglini, Donata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340653/ https://www.ncbi.nlm.nih.gov/pubmed/37443740 http://dx.doi.org/10.3390/cells12131706 |
Ejemplares similares
-
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine
por: Ciabattini, Annalisa, et al.
Publicado: (2021) -
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV
por: Polvere, Jacopo, et al.
Publicado: (2023) -
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses
por: Pettini, Elena, et al.
Publicado: (2022) -
Computational Analysis of Multiparametric Flow Cytometric Data to Dissect B Cell Subsets in Vaccine Studies
por: Lucchesi, Simone, et al.
Publicado: (2019) -
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?
por: Panza, Francesca, et al.
Publicado: (2023)